PEOPLE
Sadler to Charnwood
UK-based pre-clinical CRO Charnwood Molecular has named Dr Francesca Sadler as its new chief commercial officer . She will lead all commercial activities across business development , sales and marketing . Her previous roles were at Cyprotex , Aptuit , Charles River Discovery and , most recently , Eurofins Discovery , as SVP commercial .
New look at DSM
Following the DSM-Firmenich merger , Dimitri de Vreeze has become sole CEO . His former co-CEO , Geraldine Matchett , will leave as of 1 September , when Ralf Schmeitz , hitherto group controller , will take over the CFO role from de Vreeze . In addition , Emmanuel Butstraen and Katharina Stenholm arrived as president of the Perfumery & Beauty business and chief sustainability officer respectively on 1 July .
All change at Siegfried
Henrik Krüpper , CEO of HCS Group , will join Siegfried on 1 November to become the new COO of drug substances . The previous incumbent , Irene Wosgien , has become chief HR officer after Arnoud Middel left at the end of June . Pending Krüpper ’ s arrival , Marcel Imwinkelried will lead the DS technical operations organisation as well as being COO of drug products .
Five more years
Air Products has extended the contract of chairman , president and CEO Seifi Ghasemi to 30 September 2028 . This will automatically be extended every year on that date unless either party terminates the agreement four years ahead of its then expiration date at the latest . Ghasemi has already headed the company for nine years .
Two new at Veranova
Veranova has named Mike Riley ( pictured ) as its new CEO in place of Niek Stapel , who had led it through its sale from Johnson Matthey and relaunch . Riley has been in the CDMO sector for 19 years and was last president of Catalent ’ s Biotherapeutics business . Another industry veteran , Dr Rohtash Kumar , has joined as SVP , development operations , and chief technology officer .
Humphries heads Alcami
Bill Humphries has become CEO and board member at US CDMO Alcami after Patrick Walsh retired . He has previous pharmaceutical industry experience in senior roles at Isosceles Pharmaceuticals , Ortho-Dermatologics , Merz North America and Stiefel , among many others .
New VanDeMark CEO
Dr Boudewijn van Lent has joined VanDeMark Chemical as president and CEO . A Dutch national , van Lent has had 30 years in the chemicals industry with Lanxess , Rhein Chemie , GCP Applied Technologies and most recently DSS +, where he served as global chemical industry director .
50 SPECIALITY CHEMICALS MAGAZINE ESTABLISHED 1981